Asensus Surgical, Inc. (ASXC) stock surged +0.64%, trading at $0.35 on AMEX, up from the previous close of $0.35. The stock opened at $0.35, fluctuating between $0.35 and $0.35 in the recent session.
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.
Employees | 207 |
Beta | 1.379 |
Sales or Revenue | $8.58M |
5Y Sales Change% | -0.977% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Devices |
Asensus Surgical, Inc. (AMEX: ASXC) stock price is $0.35 in the last trading session. During the trading session, ASXC stock reached the peak price of $0.35 while $0.35 was the lowest point it dropped to. The percentage change in ASXC stock occurred in the recent session was 0.64% while the dollar amount for the price change in ASXC stock was $0.00.
The AMEX listed ASXC is part of Medical - Devices industry that operates in the broader Healthcare sector. Asensus Surgical, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Shameze Rampertab B.Sc. MBA, CA, CPA
Executive Vice President & Chief Financial Officer
Mr. Joshua B. Weingard
Chief Legal Officer & Sec.
Mr. Paul Ziegler Jr., J.D.
Vice President of Sales
Ms. Amanda Owens
Vice President of People
Dr. Stephanie M. Fitts Ph.D.
Vice President of Clinical, Quality and Regulatory Affairs
Mr. Ethan Loiselle
Vice President of Global Marketing
Mr. Anthony Fernando
Pres, Chief Executive Officer & Director
Mr. Ravi Kommineni
Head of Global Quality & Regulatory
ASXC's closing price is 105.86% higher than its 52-week low of $0.17 where as its distance from 52-week high of $0.40 is -12.87%.
Number of ASXC employees currently stands at 207.
Official Website of ASXC is: https://www.asensus.com
ASXC could be contacted at phone 919 765 8400 and can also be accessed through its website. ASXC operates from 1 TW Alexander Drive, Durham, NC 27703, United States.
ASXC stock volume for the day was 3.94M shares. The average number of ASXC shares traded daily for last 3 months was 3.26M.
The market value of ASXC currently stands at $94.92M with its latest stock price at $0.35 and 272.84M of its shares outstanding.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com